News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bapi Failure Shows Alzheimer's Disease is Even Tougher Than Cancer



8/8/2012 8:22:35 AM

I was not surprised to learn about the failure of bapineuzumab, the drug Pfizer, Johnson & Johnson, and Elan were developing as a treatment for Alzheimer’s disease. Alzheimer’s is a VERY difficult area of R&D and I have talked previously about how tough this is. What has surprised me are the negative comments that have flowed from the failure of bapineuzumab on Twitter.

Read at Forbes


comments powered by Disqus
Forbes
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES